Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$56.68 B
Marketcap
$441.51
Share price
-0.48%
Change (1 day)
45.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of June 2024 : -NZ$4.96 M

According to Alnylam Pharmaceuticals 's latest financial reports the company has -NZ$4.96 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-NZ$0.35 B40%
2022-12-31$-NZ$0.25 B-129.02%
2021-12-31$NZ$0.85 B-39.22%
2020-12-31$NZ$1.41 B-33.75%
2019-12-31$NZ$2.13 B9.93%
2018-12-31$NZ$1.94 B-22%
2017-12-31$NZ$2.48 B87.22%
2016-12-31$NZ$1.32 B-28.19%
2015-12-31$NZ$1.84 B55%
2014-12-31$NZ$1.19 B262.58%
2013-12-31$NZ$0.32 B101.32%
2012-12-31$NZ$0.16 B8.15%
2011-12-31$NZ$0.15 B-26.58%
2010-12-31$NZ$0.20 B-16.57%
2009-12-31$NZ$0.24 B-29.55%
2008-12-31$NZ$0.35 B35.93%
2007-12-31$NZ$0.25 B-9.74%
2006-12-31$NZ$0.28 B215.93%
2005-12-31$NZ$90.38 M39.78%
2004-12-31$NZ$64.66 M-257.4%
2003-12-31$-NZ$41.09 M362.8%
2002-12-31$-NZ$8.88 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.54 B-11,152.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$45.59 B-919,754.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.74 B-35,218.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.25 B-45,594.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-3,301.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$67.72 B-1,366,321.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$126.48 B-2,551,505.28%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$10.60 B-214,087.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel